Vimarsana
Biggest News Aggregation in the World

Page 38 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

Narcolepsy Med Shows Early Promise for Adult ADHD - Vimarsana News

Narcolepsy Med Shows Early Promise for Adult ADHD

Solriamfetol may be a safe and effective nonstimulant treatment for adults with ADHD, results of a small, double-blind, placebo-controlled pilot study suggest

Nintedanib Dose Reductions in IPF May Do No Harm - Vimarsana News

Nintedanib Dose Reductions in IPF May Do No Harm

Patients with idiopathic pulmonary fibrosis who required dose reductions had similar all-cause mortality and death rates vs patients on the full dose.

Many Young Adults With Type 2 Diabetes Skip Medications - Vimarsana News

Many Young Adults With Type 2 Diabetes Skip Medications

Struggles with housing and food security as well as concerns about medication side effects appear to exacerbate a lack of medication adherence.

'Reassuring' Data on Partial-Breast Radiation in Early BC - Vimarsana News

'Reassuring' Data on Partial-Breast Radiation in Early BC

A 10-year follow-up analysis found that partial-breast and reduced-dose radiation therapy were noninferior to full-breast radiation therapy among women with early breast cancer.

Tirzepatide Weight Loss Continues On and Off Drug at 1 Year - Vimarsana News

Tirzepatide Weight Loss Continues On and Off Drug at 1 Year

Those who discontinued the "twincretin" drug after 36 weeks regained weight but still maintained some weight loss at 1 year.